一种新型TrkA受体酪氨酸激酶抑制剂的鉴定。

International Journal of Medicinal Chemistry Pub Date : 2012-01-01 Epub Date: 2012-05-02 DOI:10.1155/2012/412614
Stéphane L Raeppel, Frédéric Gaudette, Hannah Nguyen, Normand Beaulieu, James Wang, Christiane Maroun, Jeffrey M Besterman, Arkadii Vaisburg
{"title":"一种新型TrkA受体酪氨酸激酶抑制剂的鉴定。","authors":"Stéphane L Raeppel,&nbsp;Frédéric Gaudette,&nbsp;Hannah Nguyen,&nbsp;Normand Beaulieu,&nbsp;James Wang,&nbsp;Christiane Maroun,&nbsp;Jeffrey M Besterman,&nbsp;Arkadii Vaisburg","doi":"10.1155/2012/412614","DOIUrl":null,"url":null,"abstract":"<p><p>A novel series of N-(3-(6-substituted-aminopyridin-3-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides targeting TrkA receptor tyrosine kinase was identified. SAR study of the series allowed us to design and synthesize compounds possessing inhibitory activity of TrkA kinase enzyme in the low nanomolar range with low residual activity against c-Met and with no significant activity against VEGFR2. </p>","PeriodicalId":14082,"journal":{"name":"International Journal of Medicinal Chemistry","volume":"2012 ","pages":"412614"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2012/412614","citationCount":"4","resultStr":"{\"title\":\"Identification of a Novel Series of Potent TrkA Receptor Tyrosine Kinase Inhibitors.\",\"authors\":\"Stéphane L Raeppel,&nbsp;Frédéric Gaudette,&nbsp;Hannah Nguyen,&nbsp;Normand Beaulieu,&nbsp;James Wang,&nbsp;Christiane Maroun,&nbsp;Jeffrey M Besterman,&nbsp;Arkadii Vaisburg\",\"doi\":\"10.1155/2012/412614\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>A novel series of N-(3-(6-substituted-aminopyridin-3-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides targeting TrkA receptor tyrosine kinase was identified. SAR study of the series allowed us to design and synthesize compounds possessing inhibitory activity of TrkA kinase enzyme in the low nanomolar range with low residual activity against c-Met and with no significant activity against VEGFR2. </p>\",\"PeriodicalId\":14082,\"journal\":{\"name\":\"International Journal of Medicinal Chemistry\",\"volume\":\"2012 \",\"pages\":\"412614\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1155/2012/412614\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Medicinal Chemistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2012/412614\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2012/5/2 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Medicinal Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2012/412614","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2012/5/2 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

摘要

鉴定了一系列靶向TrkA受体酪氨酸激酶的N-(3-(6-取代-氨基吡啶-3-基氧基)苯基)-2-氧-3-苯基咪唑烷-1-羧酰胺。该系列的SAR研究使我们能够设计和合成具有低纳摩尔范围的TrkA激酶抑制活性的化合物,对c-Met的残留活性低,对VEGFR2没有明显的活性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Identification of a Novel Series of Potent TrkA Receptor Tyrosine Kinase Inhibitors.

Identification of a Novel Series of Potent TrkA Receptor Tyrosine Kinase Inhibitors.

Identification of a Novel Series of Potent TrkA Receptor Tyrosine Kinase Inhibitors.

Identification of a Novel Series of Potent TrkA Receptor Tyrosine Kinase Inhibitors.

A novel series of N-(3-(6-substituted-aminopyridin-3-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides targeting TrkA receptor tyrosine kinase was identified. SAR study of the series allowed us to design and synthesize compounds possessing inhibitory activity of TrkA kinase enzyme in the low nanomolar range with low residual activity against c-Met and with no significant activity against VEGFR2.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊介绍: International Journal of Medicinal Chemistry is a peer-reviewed, Open Access journal that publishes original research articles as well as review articles in all areas of chemistry associated with drug discovery, design, and synthesis. International Journal of Medicinal Chemistry is a peer-reviewed, Open Access journal that publishes original research articles as well as review articles in all areas of chemistry associated with drug discovery, design, and synthesis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信